DK586585D0 - Hunde- og heste-interferoner, deres fremstilling og anvendelse - Google Patents

Hunde- og heste-interferoner, deres fremstilling og anvendelse

Info

Publication number
DK586585D0
DK586585D0 DK586585A DK586585A DK586585D0 DK 586585 D0 DK586585 D0 DK 586585D0 DK 586585 A DK586585 A DK 586585A DK 586585 A DK586585 A DK 586585A DK 586585 D0 DK586585 D0 DK 586585D0
Authority
DK
Denmark
Prior art keywords
dog
horse
interferones
preparation
interferons
Prior art date
Application number
DK586585A
Other languages
English (en)
Other versions
DK167929B1 (da
DK586585A (da
Inventor
A Himmler
R Hauptmann
N Hauel
G Adolf
P Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DK586585D0 publication Critical patent/DK586585D0/da
Publication of DK586585A publication Critical patent/DK586585A/da
Application granted granted Critical
Publication of DK167929B1 publication Critical patent/DK167929B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK586585A 1984-12-18 1985-12-17 Rekombinant dna-molekyle indeholdende en for hesteinterferoner kodende sekvens, transformeret vaertsorganisme indeholdende dna-molekylet, interferon kodet af det rekombinante dna-molekyle, fremgangsmaade til fremstilling af heste-interferoner, anvendelse af interferonerne, middel til terapeutisk behandling samt heste-interferon til anvendelse som laegemiddel DK167929B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE3446124 1984-12-18
DE3446124 1984-12-18
DE3446122 1984-12-18
DE3446122 1984-12-18
DE3529262 1985-08-16
DE3529262 1985-08-16
DE3535115 1985-10-02
DE3535115 1985-10-02

Publications (3)

Publication Number Publication Date
DK586585D0 true DK586585D0 (da) 1985-12-17
DK586585A DK586585A (da) 1986-06-19
DK167929B1 DK167929B1 (da) 1994-01-03

Family

ID=27433247

Family Applications (1)

Application Number Title Priority Date Filing Date
DK586585A DK167929B1 (da) 1984-12-18 1985-12-17 Rekombinant dna-molekyle indeholdende en for hesteinterferoner kodende sekvens, transformeret vaertsorganisme indeholdende dna-molekylet, interferon kodet af det rekombinante dna-molekyle, fremgangsmaade til fremstilling af heste-interferoner, anvendelse af interferonerne, middel til terapeutisk behandling samt heste-interferon til anvendelse som laegemiddel

Country Status (19)

Country Link
US (2) US5605688A (da)
EP (1) EP0186098B1 (da)
JP (1) JPH0753596A (da)
KR (1) KR940010864B1 (da)
AT (1) ATE77410T1 (da)
AU (1) AU604634B2 (da)
CA (1) CA1339954C (da)
DE (1) DE3544520C2 (da)
DK (1) DK167929B1 (da)
ES (1) ES8704515A1 (da)
FI (1) FI90990C (da)
GR (1) GR853062B (da)
HU (1) HU212836B (da)
IE (1) IE58685B1 (da)
IL (1) IL77369A (da)
NO (1) NO176057C (da)
NZ (1) NZ214602A (da)
PT (1) PT81691B (da)
WO (1) WO1986003775A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
DE3932311A1 (de) * 1989-09-28 1991-04-11 Boehringer Ingelheim Int Verfahren zur reinigung von beta-interferon
US6482403B1 (en) 1998-05-29 2002-11-19 Heska Corporation Caniney IL-13 immunoregulatory proteins and uses thereof
USRE40374E1 (en) 1998-05-29 2008-06-10 Heska Corporation Canine IL-13 immunoregulatory proteins and uses thereof
JP2002516104A (ja) 1998-05-29 2002-06-04 ヘスカ コーポレイション イヌ及びネコ免疫調節たんぱく、核酸分子、及びこれらの利用法
US20020127200A1 (en) 1998-05-29 2002-09-12 Shumin Yang Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
EP1121156B1 (en) 1998-10-16 2006-02-22 Biogen Idec MA Inc. Polymer conjugates of interferon beta- 1a and their uses
US20020197235A1 (en) * 2000-11-03 2002-12-26 Moran Stanford Mark Method for short-term and long-term drug dosimetry
JP2005516041A (ja) * 2001-11-09 2005-06-02 インターシア・セラピューティクス・インコーポレイテッド オメガインターフェロンを用いる疾患の治療方法
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
KR101200728B1 (ko) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 삼투성 전달 시스템 및 피스톤 조립체
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
MX352878B (es) 2009-09-28 2017-12-13 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
ES2666850T3 (es) 2011-03-15 2018-05-08 Biogen Ma Inc. Procedimiento para reducir los síntomas similares a gripe asociados a la administración intramuscular de interferón usando un régimen de dosificación creciente de titulación rápida
CN102321169A (zh) * 2011-09-30 2012-01-18 长春工业大学 一种犬重组干扰素α及制备方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP4278996A3 (en) 2015-06-03 2024-01-24 i2o Therapeutics, Inc. Implant placement systems
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
CN108424915A (zh) * 2018-01-12 2018-08-21 中国农业科学院北京畜牧兽医研究所 犬干扰素-α2重组蛋白的制备方法
CN108486127A (zh) * 2018-01-12 2018-09-04 中国农业科学院北京畜牧兽医研究所 犬干扰素-α6α7重组蛋白及其制备方法与应用
CN111233998B (zh) * 2018-08-02 2021-10-19 中国农业科学院北京畜牧兽医研究所 一种犬干扰素CaIFN-λ突变体及其应用
GB202011945D0 (en) * 2020-07-31 2020-09-16 Ilc Therapeutics Ltd Compositions and methods relating to the treatment of diseases
CN112079912B (zh) * 2020-09-25 2022-05-06 广州源博医药科技有限公司 一种高活性的犬α干扰素重组蛋白及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
US4436815A (en) * 1981-11-27 1984-03-13 Eli Lilly And Company Method for stabilizing and selecting recombinant DNA containing host cells
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor

Also Published As

Publication number Publication date
DE3544520A1 (de) 1986-12-18
HU212836B (en) 1996-12-30
DK167929B1 (da) 1994-01-03
NO176057C (no) 1995-01-25
FI854994A0 (fi) 1985-12-16
NZ214602A (en) 1991-06-25
PT81691B (pt) 1988-04-21
HUT40165A (en) 1986-11-28
US5798228A (en) 1998-08-25
FI854994A (fi) 1986-06-19
ES8704515A1 (es) 1987-04-01
WO1986003775A1 (en) 1986-07-03
PT81691A (de) 1986-01-01
AU5132085A (en) 1986-06-26
CA1339954C (en) 1998-07-14
ATE77410T1 (de) 1992-07-15
US5605688A (en) 1997-02-25
NO176057B (no) 1994-10-17
IE58685B1 (en) 1994-02-09
JPH0753596A (ja) 1995-02-28
EP0186098A1 (de) 1986-07-02
FI90990B (fi) 1994-01-14
DE3544520C2 (de) 1995-07-20
FI90990C (fi) 1994-04-25
KR940010864B1 (ko) 1994-11-18
IL77369A (en) 1993-07-08
NO855078L (no) 1986-06-19
EP0186098B1 (de) 1992-06-17
ES550043A0 (es) 1987-04-01
GR853062B (da) 1986-04-21
IE853194L (en) 1986-06-18
AU604634B2 (en) 1991-01-03
KR860005020A (ko) 1986-07-16
DK586585A (da) 1986-06-19

Similar Documents

Publication Publication Date Title
DK586585D0 (da) Hunde- og heste-interferoner, deres fremstilling og anvendelse
DE3584937D1 (de) Schimmelbekaempfungsmittel.
NO902446D0 (no) Dyrefor og fremgangsmaater for deres fremstilling.
DK15187A (da) 4,5,6-substituerede-n-(substitueret phenyl)-2-pyrimidinaminer, deres fremstilling og anvendelse
DE3872503T2 (de) Kuehlungsregelsystem.
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
FI850275L (fi) Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat.
BR8505703A (pt) Ferradura equina
FI862107A (fi) Saekerhetssits foer barn.
FI850827A0 (fi) Saetesutrustning foer barn i fordon.
NO880197D0 (no) Pelsdyrfor og fremgangsmaate til fremstilling derav.
DE3854023D1 (de) Drahtloses Steuerungssystem.
DE3677688D1 (de) Kuenstliches pelzwerk.
DE3766496D1 (de) Stellzylinder.
FI844410L (fi) Slaepvagn med avlastning.
DE3577475D1 (de) Gefechtskopf.
IT8421163V0 (it) Apparecchio sollevatore per bovini.
BR6501041U (pt) Cavalete visual-a.
KR860004595A (ko) 동물성 가수 단백분해물 제조방법
DK189185D0 (da) (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)-pentanoler, deres fremstilling og anvendelse
IT212521Z2 (it) Perfezionamento nelle lampade cimiteriali,in particolare per colombari
NO164151C (no) Hestesko, saerlig for travhester.
ES1006222Y (es) Herradura perfeccionada.
FI853365L (fi) Koer- och handbroms foer fordon.
FI844101A0 (fi) Glidbana foer barn.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed